Search Medical Condition
Please enter condition
Please choose location

Heart Failure Clinical Trials

A listing of Heart Failure medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (307) clinical trials

A research study is evaluating an investigational medication for heart failure. This research study may be an option if you: Have been diagnosed with heart failure Are currently being treated for heart failure Have an ejection fraction (LVEF) of 40% or less Do not have type 1 diabetes Do not ...

Phase N/A

A research study is evaluating an investigational oral medication for Chronic Heart Failure. This research study may be an option if you: Are between 18 and 85 years of age Have been diagnosed with chronic heart failure and have been receiving treatment for at least 30 days Have not had ...

Phase N/A

Male and female subjects aged 18 years or older, with chronic HF (NYHA class II-IV), reduced ejection fraction (< 45%), elevated natriuretic peptides, and previous HFdecompensation (defined as HF hospitalization or use of IV diuretics for HF [without hospitalization]) will be enrolled in this trial.

Phase N/A

This is an observational study which does not require any additional office visits or medicine outside of normal care. The study will look at the treatment of heart failure and reasons for changes in treatment. The information gathered in this study may help doctors and researchers better understand how different ...

Phase N/A

PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE, 2-PART STUDY TO ASSESS THE SAFETY, TOLERABILITY AND PHARMACOKINETIC RESPONSE AND EXPLORE THE PHARMACODYNAMIC RESPONSE FOLLOWING 4 WEEKS OF ONCE WEEKLY SUBCUTANEOUS INJECTIONS OF PB1046 IN ADULT SUBJECTS WITH STABLE HEART FAILUREWITH REDUCED EJECTION FRACTION (HFREF) (PART 1) AND IN SUBJECTS WITH CARDIAC DYSFUNCTION ...

Phase

The objective of this event-driven trial is to demonstrate superiority of empagliflozin 10 mg versus placebo in patients with symptomatic, chronic HF and preserved ejection fraction (LVEF > 40%) under stable treatment of HF symptoms. The trial will be performed in patients with chronic heart failure with an ejection fraction ...

Phase

The objective of this event-driven trial is to demonstrate superiority of empagliflozin 10 mg versus placebo on top of guideline-directed medical therapy in patients with symptomatic, chronic HF and reduced ejection fraction (LVEF ≤ 40%). Patients with chronic HF diagnosed for at least 3 months before Visit 1.

Phase

The purpose of this trial is to develop valid scientific evidence for safety and effectiveness of Baroreflex Activation Therapy® with the BAROSTIM NEO® System in subjects with heart failure, defined as New York Heart Association (NYHA) functional class III and left ventricular ejection fraction (LVEF) = 35% despite being treated ...

Phase N/A

Multi-center, prospective, single-arm, continued access study of the Optimizer Smart System with CCM therapy. All subjects will be followed until the PMA order has been issued by the FDA. The protocol is designed to collect adverse safety events, quality of life data and data needed for comparison with long term ...

Phase N/A

People with Heart Failure are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A